408 related articles for article (PubMed ID: 28330645)
1. Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium.
Luo D; Kim JH; Park C; Oh E; Park JB; Cui JH; Cao QR; Lee BJ
Int J Pharm; 2017 May; 523(1):343-356. PubMed ID: 28330645
[TBL] [Abstract][Full Text] [Related]
2. Roles of MgO release from polyethylene glycol 6000-based solid dispersions on microenvironmental pH, enhanced dissolution and reduced gastrointestinal damage of telmisartan.
Tran PH; Tran TT; Lee SA; Nho VH; Chi SC; Lee BJ
Arch Pharm Res; 2011 May; 34(5):747-55. PubMed ID: 21656360
[TBL] [Abstract][Full Text] [Related]
3. Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage.
Tran PH; Tran TT; Park JB; Min DH; Choi HG; Han HK; Rhee YS; Lee BJ
Int J Pharm; 2011 Jul; 414(1-2):48-55. PubMed ID: 21565260
[TBL] [Abstract][Full Text] [Related]
4. Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release.
Tran PH; Tran HT; Lee BJ
J Control Release; 2008 Jul; 129(1):59-65. PubMed ID: 18501462
[TBL] [Abstract][Full Text] [Related]
5. Amorphous ternary cyclodextrin nanocomposites of telmisartan for oral drug delivery: improved solubility and reduced pharmacokinetic variability.
Sangwai M; Vavia P
Int J Pharm; 2013 Sep; 453(2):423-32. PubMed ID: 22935741
[TBL] [Abstract][Full Text] [Related]
6. Enhanced gastric stability of esomeprazole by molecular interaction and modulation of microenvironmental pH with alkalizers in solid dispersion.
Van Nguyen H; Baek N; Lee BJ
Int J Pharm; 2017 May; 523(1):189-202. PubMed ID: 28342789
[TBL] [Abstract][Full Text] [Related]
7. Improved pH-dependent drug release and oral exposure of telmisartan, a poorly soluble drug through the formation of drug-aminoclay complex.
Yang L; Shao Y; Han HK
Int J Pharm; 2014 Aug; 471(1-2):258-63. PubMed ID: 24834880
[TBL] [Abstract][Full Text] [Related]
8. Development of Bilayer Tablets with Modified Release of Selected Incompatible Drugs.
Dhiman N; Awasthi R; Jindal S; Khatri S; Dua K
Polim Med; 2016; 46(1):5-15. PubMed ID: 28397414
[TBL] [Abstract][Full Text] [Related]
9. Development of an enteric coating formulation and process for tablets primarily composed of a highly water-soluble, organic acid.
Crotts G; Sheth A; Twist J; Ghebre-Sellassie I
Eur J Pharm Biopharm; 2001 Jan; 51(1):71-6. PubMed ID: 11154906
[TBL] [Abstract][Full Text] [Related]
10. Soluble telmisartan bearing poly (ethylene glycol) conjugated chitosan nanoparticles augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in human cervical cancer cells.
Sharma A; Jyoti K; Bansal V; Jain UK; Bhushan B; Madan J
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():69-76. PubMed ID: 28024639
[TBL] [Abstract][Full Text] [Related]
11. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective.
Dukeck R; Sieger P; Karmwar P
Eur J Pharm Sci; 2013 Jul; 49(4):723-31. PubMed ID: 23684913
[TBL] [Abstract][Full Text] [Related]
12. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
Lee BJ; Ryu SG; Cui JH
Int J Pharm; 1999 Oct; 188(1):71-80. PubMed ID: 10528084
[TBL] [Abstract][Full Text] [Related]
13. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
[TBL] [Abstract][Full Text] [Related]
14. Solid state properties and drug release behavior of co-amorphous indomethacin-arginine tablets coated with Kollicoat® Protect.
Petry I; Löbmann K; Grohganz H; Rades T; Leopold CS
Eur J Pharm Biopharm; 2017 Oct; 119():150-160. PubMed ID: 28602869
[TBL] [Abstract][Full Text] [Related]
15. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
[TBL] [Abstract][Full Text] [Related]
16. Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters.
Riekes MK; Dereymaker A; Berben P; Augustijns P; Stulzer HK; Van den Mooter G
Int J Pharm; 2017 Mar; 520(1-2):49-58. PubMed ID: 28153650
[TBL] [Abstract][Full Text] [Related]
17. Stability and Bioavailability Enhancement of Telmisartan Ternary Solid Dispersions: the Synergistic Effect of Polymers and Drug-Polymer(s) Interactions.
Shi X; Xu T; Huang W; Fan B; Sheng X
AAPS PharmSciTech; 2019 Mar; 20(4):143. PubMed ID: 30887265
[TBL] [Abstract][Full Text] [Related]
18. Formulation and Development of Novel Sulfasalazine Bilayer Tablets for The Treatment of Arthritis Associated With IBD: In-vitro and In-vivo Investigations.
Jadiya S; Upmanyu N; Sathiyanarayanan A; Jain V; Dubey R; Buwade P
J Pharm Sci; 2024 Jul; 113(7):1919-1926. PubMed ID: 38401631
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of pH-independent sustained release tablet containing solid dispersion granules of a poorly water-soluble drug.
Tran HT; Park JB; Hong KH; Choi HG; Han HK; Lee J; Oh KT; Lee BJ
Int J Pharm; 2011 Aug; 415(1-2):83-8. PubMed ID: 21641985
[TBL] [Abstract][Full Text] [Related]
20. [Preparation and evaluation of press-coated aminophylline tablet using crystalline cellulose and polyethylene glycol in the outer shell for timed-release dosage forms].
Watanabe Y; Mukai B; Kawamura K; Ishikawa T; Namiki M; Utoguchi N; Fujii M
Yakugaku Zasshi; 2002 Feb; 122(2):157-62. PubMed ID: 11857956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
